Malattie cardiovascolari e diabete

Per visualizzare la bibliografia è sufficiente selezionare l'icona del mese corrispondente.
Cliccando sul titolo degli articoli potrai leggerne l'abstract.

giu 2010

mag 2010

apr 2010

mar 2010

feb 2010

gen 2010

dic 2009

nov 2009

ott 2009

set 2009

Scand J Clin Lab Invest 2007 67(8):786-800
Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
Johansen O

---

Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008 105(2):173-9
Oral infection, hyperglycemia, and endothelial dysfunction.
Janket SJ, Jones JA, Meurman JH, Baird AE, Van Dyke T

---

Clin Sci (Lond) 2008 114(4):313-20
Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes.
Srivastava PM, Calafiore P, Macisaac RJ, Patel SK, Thomas MC, Jerums G, Burrell L

---

Heart 2008 94(2):e4
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B, ASCOT trial investigats

---

BMC Fam Pract 2007 8():59
Prevalence of risk factors for diabetic foot complications.
Al-Maskari F, El-Sadig

---

J Neurochem 2008 104(2):386-99
Glial cell-derived glutamate mediates autocrine cell volume regulation in the retina: activation by VEGF.
Wurm A, Pannicke T, Wiedemann P, Reichenbach A, Bringmann

---

Clin Pharmacol Ther 2008 83(2):354-7
K(ATP) channel pharmacogenomics: from bench to bedside.
Sattiraju S, Reyes S, Kane GC, Terzic

---

Br J Ophthalmol 2008 92(2):213-6
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.
Arevalo JF, Maia M, Flynn HW, Saravia M, Avery RL, Wu L, Eid Farah M, Pieramici DJ, Berrocal MH, Sanchez J

---

Cardiovasc Diabetol 2007 6():34
Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development.
Kumar SD, Dheen ST, Tay S

---

Circ Res 2008 102(1):95-102
Diabetes-induced coronary vascular dysfunction involves increased arginase activity.
Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, Caldwell RB, Caldwell R

---

Age Ageing 2008 37(1):77-82
The association between urinary albumin excretion and ankle-brachial index in elderly Taiwanese patients with type 2 diabetes mellitus.
Tseng CH, Chong CK, Tseng CP, Tai T

---

Arterioscler Thromb Vasc Biol 2008 28(2):341-7
Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, Alshiek J, Bennett L, Kostenko M, Landau M, Keidar S, Levy Y, Khemlin A, Radan A, Levy A

---

Cardiovasc Diabetol 2007 6():37
Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry.
Yang X, Ma RC, So WY, Ko GT, Kong AP, Lam CW, Ho CS, Cockram CS, Wong VC, Tong PC, Chan J

---

Circulation 2008 117(1):43-51
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbély A, van der Velden J, Stienen GJ, Laarman GJ, Niessen HW, Paulus W

---

Biochem Biophys Res Commun 2008 366(3):814-20
Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice.
Goto H, Nishikawa T, Sonoda K, Kondo T, Kukidome D, Fujisawa K, Yamashiro T, Motoshima H, Matsumura T, Tsuruzoe K, Araki

---

Circulation 2008 117(1):93-102
Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen P

---

Stroke 2008 39(2):384-9
Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial.
Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, Kissela BM, Williams L

---

Ophthalmology 2008 115(1):216-216.e1
Subthreshold laser.
Lanzetta P, Polito A, Veritti

---

Chin Med J (Engl) 2007 120(24):2218-23
Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population.
Chen SF, Lu XF, Yan WL, Huang JF, Gu D

---

J Assoc Physicians India 2007 55():693-9
Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
Ahmad J, Ahmned F, Siddiqui MA, Khan AR, Katyal P, Hameed B, Ahmad

---

Clin Experiment Ophthalmol 2007 35(9):824-7
Oral sodium fluorescein to improve visualization of clear vitreous during vitrectomy for proliferative diabetic retinopathy.
Yao Y, Wang ZJ, Wei SH, Huang YF, Zhang M

---

Clin Experiment Ophthalmol 2007 35(9):847-54
Early electroretinographic features of streptozotocin-induced diabetic retinopathy.
Shinoda K, Rejdak R, Schuettauf F, Blatsios G, Völker M, Tanimoto N, Olcay T, Gekeler F, Lehaci C, Naskar R, Zagorski Z, Zrenner

---

Curr Atheroscler Rep 2007 9(4):286-95
Lipid goals in metabolic syndrome and diabetes.
Colhoun H

---

Circ Res 2008 102(1):9-11
Sweet and sour: unraveling diabetic vascular disease.
Luscher TF, Steffel

---

Wiad Lek 2007 60(7-8):329-34
[Oxidative-antioxidative balance disturbance and risk factors as well as vascular complications in patients with diabetes type 2]
Knapik-Kordecka M, Piwowar A, Warwas

---

Wiad Lek 2007 60(7-8):381-5
[Maggots of Lucilia sericata in treatment of intractable wounds]
Orkiszewski

---

Curr Hypertens Rep 2007 9(5):393-402
Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?
Alicic R, Tuttle K

---

Curr Hypertens Rep 2007 9(5):403-8
Dual effects of RAS blockade on blood pressure and podocyte function.
Reiser J, Mundel

---

Curr Hypertens Rep 2007 9(5):415-21
Renin inhibitors: optimal strategy for renal protection.
Schmieder R

---

Lancet 2008 371(9606):25; author reply 26
The ADVANCE trial.
Fuchs F

---

Lancet 2008 371(9606):25; author reply 26
The ADVANCE trial.
Procopiou

---

Clin J Am Soc Nephrol 2008 3(1):163-7
Does lowering of blood glucose improve cardiovascular morbidity and mortality?
Iqbal N, Rubenstein A

---

J Indian Med Assoc 2007 105(7):370, 372, 374 passim
A study on body mass index (BMI) and some biochemical parameters of the medicos with family history of diabetes mellitus, hypertension and coronary heart disease.
Bhattacharyya S, Mukhopadhyay M, Bhattacharyya I, Lahiri SK, Mitra PK, Dutta U

---

Soins Pediatr Pueric 2007 (239):20-2
[The health consequences of child obesity]
Tounian

---

J Am Geriatr Soc 2008 56(1):180-1
The prevalence of at-risk foot in patients with diabetes mellitus, patients without diabetes mellitus with neurological disorders, and subjects without known diabetes mellitus or lower limb sensory loss.
Pataky Z, Herrmann FR, Regat D, Vuagnat

---

N Engl J Med 2008 358(2):193; author reply 194-5
Long-term follow-up of the West of Scotland Coronary Prevention Study.
McEvoy JW, Margey R, Blake G

---

Lancet 2008 371(9607):94-5
Statins for people with diabetes.
Cheung B

---

Lancet 2008 371(9607):114; author reply 114-5
Day or night blood pressures for prognosis.
Pandey NR, Nandan N, Rai

---

Lancet 2008 371(9607):117-25
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
Cholesterol Treatment Trialists' (CTT) CollaboratorsKearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent

---

Zh Nevrol Psikhiatr Im S S Korsakova 2006 Suppl 17():47-51
[A short-term effect of lovastatin on lipoprotein metabolism in patients with cerebrovascular lesions concomitant with diabetes mellitus II type]
Bozhko GKh, Sokolik VV, Chursina VS, Pertseva T

---

Subcell Biochem 2007 45():1-28
Annexinopathies.
Hayes MJ, Longbottom RE, Evans MA, Moss S

---

Subcell Biochem 2007 45():273-321
Diseases associated with altered ryanodine receptor activity.
Durham WJ, Wehrens XH, Sood S, Hamilton S

---

Subcell Biochem 2007 45():337-63
SERCA pumps and human diseases.
Hovnanian

---

Endocr Pract 13(7):705-10
Evaluation of admission blood glucose levels in the intensive care unit.
Fish LH, Moore AL, Morgan B, Anderson R

---

Endocr Pract 13(7):790-804
Role of the endocannabinoid system in management of patients with type 2 diabetes mellitus and cardiovascular risk factors.
Davis SN, Perkins J

---

Heart 2008 94(2):145-52
Drug-eluting stents: a critique.
Melikian N, Wijns

---

Arch Neurol 2008 65(1):89-93
Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer L

---

Am J Manag Care 2008 14(1):53-4; author reply 54-5
Unrecognized confounders in overcoming clinical inertia study.
Federman D

---

Am J Manag Care 2008 14(1):54; author reply 54-5
Lowering LDL-C for optimal protection in high-risk patients.
Shaley F

---

West Indian Med J 2007 56(4):355-63
Report from the Caribbean renal registry, 2006.
Soyibo AK, Barton E

---

N Engl J Med 2008 358(3):293-7
Clinical decisions. Management of type 2 diabetes.
Goldberg RB, Holman R, Drucker D

---

Drugs 2006 66 Spec No 1():22-4
[J-MIND study: effect of nifedipine on renal function in Japanese hypertensive patients with diabetes mellitus]
Yoshino

---

Scand J Immunol 2008 67(2):204-8
Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus.
Zorena K, Mysliwska J, Mysliwiec M, Balcerska A, Lipowski P, Raczynska

---

J Neurol Neurosurg Psychiatry 2008 79(2):209-11
Causes of death in pedigrees with the 3243A>G mutation in mitochondrial DNA.
Majamaa-Voltti K, Turkka J, Kortelainen ML, Huikuri H, Majamaa

---

Clin Microbiol Rev 2008 21(1):209-24
Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography.
Kumar R, Basu S, Torigian D, Anand V, Zhuang H, Alavi

---

Kans Nurse 82(10):3-5
The genetics of chronic disease: a nursing perspective.
Elder B

---

J Am Coll Cardiol 2008 51(3):264-70
Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS, Pencina MJ, D'Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox C

---

Gynakol Geburtshilfliche Rundsch 2008 48(1):16-23
[The polycystic ovary syndrome--metabolic consequences]
Tan S, Hahn S, Janssen O

---

Pain Pract 2008 8(1):45-56
A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions.
Sadosky A, McDermott AM, Brandenburg NA, Strauss

---

Clin Exp Hypertens 2008 30(1):33-43
Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparison between diabetic nephropathy and non-diabetic glomerulopathy.
Tamura K, Yamauchi J, Tsurumi-Ikeya Y, Sakai M, Ozawa M, Shigenaga A, Azuma K, Okano Y, Ishigami T, Toya Y, Yabana M, Tokita Y, Ohnishi T, Umemura

---

Am Heart J 2008 155(2):215-23
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.
Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, Cohen DJ, Mahoney E, Sleeper L, King S, Domanski M, McKinlay S, Fuster

---

Am Heart J 2008 155(2):284-9
Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus.
Porter A, Assali AR, Zahalka A, Iakobishvili Z, Brosh D, Lev EI, Mager A, Battler A, Kornowski R, Hasdai

---

Angiology 58(6):689-97
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
Athyros VG, Liberopoulos EN, Mikhailidis DP, Papageorgiou AA, Ganotakis ES, Tziomalos K, Kakafika AI, Karagiannis A, Lambropoulos S, Elisaf

---

Angiology 58(6):698-703
Identifying cardiovascular risk factors in a patient population with coronary artery ectasia.
Saglam M, Karakaya O, Barutcu I, Esen AM, Turkmen M, Kargin R, Esen O, Ozdemir N, Kaymaz

---

Thromb Haemost 2008 99(1):14-26
Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review.
Crescente M, Di Castelnuovo A, Iacoviello L, Vermylen J, Cerletti C, de Gaetano

---

Diabetes Forecast 2007 60(13):64-6
Research profile. Places in the heart. Pinpointing the cause of cardiovascular complications.
Liu

---

Ter Arkh 2007 79(12):12-8
[A circadian profile of arterial pressure in hypertensive patients with diabetes mellitus: relation with affected renal circulation]
Karpov RS, Koshel'skaia O

---

Ter Arkh 2007 79(12):38-43
[Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting]
Tepliakov AT, Kuznetsova AV, Lukinov AV, Levshin A

---

Curr Pharm Des 2007 13(36):3681-7
Advanced glycation: a novel outlook on atherosclerosis.
Price CL, Knight S

---

Recent Patents Cardiovasc Drug Discov 2006 1(1):79-83
Telmisartan, its potential therapeutic implications in cardiometabolic disorders.
Yamagishi S, Nakamura

---

Recent Patents Cardiovasc Drug Discov 2006 1(2):167-75
Therapeutic targeting of endothelial dysfunction in chronic diabetic complications.
Khan ZA, Chakrabarti

---

Recent Patents Cardiovasc Drug Discov 2007 2(1):35-9
Ranolazine, a partial fatty acid oxidation inhibitor, its potential benefit in angina and other cardiovascular disorders.
Bhandari B, Subramanian

---

Exp Diabetes Res 2007 2007():61038
The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.
Lorenzi

---

Nat Clin Pract Nephrol 2008 4(2):80-9
Hereditary etiologies of hypomagnesemia.
Naderi AS, Reilly R

---

Expert Opin Investig Drugs 2008 17(2):145-67
Glucokinase activators in diabetes management.
Coghlan M, Leighton

---

Eur J Endocrinol 2008 158(2):153-61
Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients.
Schneider HJ, Klotsche J, Saller B, Böhler S, Sievers C, Pittrow D, Ruf G, März W, Erwa W, Zeiher AM, Silber S, Lehnert H, Wittchen HU, Stalla G

---

Indian J Public Health 51(4):225-7
A study on hypertension among the bank employees of Meerut district of Uttar Pradesh.
Maroof KA, Parashar P, Bansal R, Ahmad

---

Indian J Public Health 51(4):228-30
Awareness of diabetic retinopathy among physicians and optometrists in a district of West Bengal.
Ghosh S, Mukhopadhyay S, Maji D, Halder

---

Lakartidningen 2007 104(51-52):3857-61
[The metabolic syndrome threatens public health. Increased physical activity the best cure]
Hellénius ML, Rauramaa

---

Dtsch Med Wochenschr 2008 133(6):261-2; author reply 262-3
[Glitazone - mailing no 3. In response to DMW 49/2007]
Gundel U

---

Dtsch Med Wochenschr 2008 133(6):261; author reply 262-3
[Glitazone - mailing no 2. In response to DMW 49/2007]
Kerner

---

Dtsch Med Wochenschr 2008 133(6):261; author reply 262-3
[Glitazone - mailing no 1. In response to DMW 49/2007]
Traut

---

Dtsch Med Wochenschr 2008 133(6):262; author reply 262-3
[Glitazone - mailing no 4. In response to DMW 49/2007]
Strohmeyer T, Seidel

---

Curr Med Res Opin 2008 24(1):79-85
Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes.
Wysham C, Lush C, Zhang B, Maier H, Wilhelm

---

J Am Soc Nephrol 2008 19(1):135-40
Chronic kidney disease increases risk for venous thromboembolism.
Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom A

---

Curr Med Res Opin 2008 24(1):275-86
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.
Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs D

---

J Am Soc Nephrol 2008 19(1):182-7
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.
Schneider CA, Ferrannini E, Defronzo R, Schernthaner G, Yates J, Erdmann

---

J Clin Ultrasound 2008 36(2):85-90
Renal and carotid vascular resistance assessed with Doppler sonography.
Ohta Y, Fujii K, Ibayashi S, Matsumura K, Tsuchihashi T, Kitazono T, Ooboshi H, Kamouchi M, Hirakata H, Ogata T, Kuroda J, Iida

---

J Intern Med 2008 263(2):203-11
Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents.
Denollet J, Pedersen SS, Daemen J, de Jaegere P, Serruys PW, van Domburg R

---

Telemed J E Health 2007 13(6):635-44
The relationship of a diabetes telehealth eye care program to standard eye care and change in diabetes health outcomes.
Fonda SJ, Bursell SE, Lewis DG, Garren J, Hock K, Cavallerano

---

Hypertension 2008 51(2):393-8
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.
Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K, Sato T, Saruta T, Candesartan Antihypertensive Survival Evaluation in Japan Trial Grp

---

J Clin Hypertens (Greenwich) 2008 10(1):27-33
Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study.
Saunders E, Cable G, Neutel

---

J Clin Hypertens (Greenwich) 2008 10(1):51-7
Treatment with metoprolol succinate, a selective beta adrenergic blocker, lowers blood pressure without altering insulin sensitivity in diabetic patients.
Falkner B, Kushner

---

J Clin Hypertens (Greenwich) 2008 10(1):77-80
The newly identified hypertensive patient: cost-effective laboratory investigation.
Handler

---

Drugs Today (Barc) 2007 43(11):815-26
The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
Triggle C

---

Semin Thromb Hemost 2007 33(8):798-809
Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.
Mina A, Favaloro EJ, Koutts

---

Am J Clin Nutr 2008 87(1):258S-268S
Glycemic response and health--a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes.
Livesey G, Taylor R, Hulshof T, Howlett

---

J Vasc Surg 2008 47(1):101-8
Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia.
DeRubertis BG, Pierce M, Ryer EJ, Trocciola S, Kent KC, Faries P

---

Clin J Am Soc Nephrol 2008 3 Suppl 1():S3-10
Slowing nephropathy progression: focus on proteinuria reduction.
Bakris G

---

J Am Soc Nephrol 2008 19(1):4-7
Cardiovascular disease, chronic kidney disease, and type 2 diabetes mellitus: proceeding with caution at a dangerous intersection.
Kanda T, Wakino S, Hayashi K, Plutzky

---

Hypertension 2008 51(2):534-9
Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes.
Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M, Nishida W, Okura T, Higaki J, Makino

---

Curr Opin Endocrinol Diabetes Obes 2008 15(1):21-9
Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
Nathan BM, Moran

---

Retina 2008 28(1):36-40
Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema.
Scott IU, Bressler NM, Bressler SB, Browning DJ, Chan CK, Danis RP, Davis MD, Kollman C, Qin H, Diabetic Retinopathy Clinical Research Network Study Grp

---

Retina 2008 28(1):187-8; author reply 188-9
Pars plana vitrectomy with and without peeling of the inner limiting membrane (ILM) for diabetic macular edema.
Gandorfer A, Kampik

---

J Diabetes Complications 22(1):1-9
Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
Bertoni AG, Clark JM, Feeney P, Yanovski SZ, Bantle J, Montgomery B, Safford MM, Herman WH, Haffner S, Look AHEAD Research Grp

---

J Diabetes Complications 22(1):10-7
Coronary heart disease among diabetic and nondiabetic people - socioeconomic differences in incidence, prognosis and mortality.
Forssas EH, Keskimäki IT, Reunanen AR, Koskinen S

---

J Diabetes Complications 22(1):18-23
The metabolic syndrome in type 1 diabetes: does it exist and does it matter?
McGill M, Molyneaux L, Twigg SM, Yue D

---

J Diabetes Complications 22(1):24-8
Predictors of postoperative complications in the patient with diabetes mellitus.
Tao LS, Mackenzie CR, Charlson M

---

J Diabetes Complications 22(1):62-75
Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
Dandona P, Ghanim H, Chaudhuri A, Mohanty

---

J Gastrointestin Liver Dis 2007 16(4):449-51
Minimally invasive surgical treatment of morbid obesity in patients with specific comorbidities. A case report.
Constantea N, Axente D, Miclaus D, Dudric V, Jianu F, Bodolea

---

Hypertension 2008 51(2):177-8
Vascular stiffness and the "chicken-or-the-egg" question.
Glasser SP, Arnett D

---

Arch Intern Med 2008 168(1):109
Cardiovascular safety of low-dose rosiglitazone.
Mikhail

---

Arch Intern Med 2008 168(1):111; author reply 111
Estimating cardiovascular risk.
Seidel BM, Stocks

---

Vasc Health Risk Manag 2007 3(6):783-95
Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension.

---

Vasc Health Risk Manag 2007 3(6):947-58
Inhaled insulin for controlling blood glucose in patients with diabetes.
Silverman BL, Barnes CJ, Campaigne BN, Muchmore D

---

Vasc Health Risk Manag 2007 3(6):967-73
A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications.
Molavi B, Rassouli N, Bagwe S, Rasouli

---

Vasc Health Risk Manag 2007 3(6):985-97
Rationale for multiple risk intervention: the need to move from theory to practice.
Erhardt L

---

Vasc Health Risk Manag 2007 3(6):1063-8
Adult nontwin sib concordance rates for type 2 diabetes, hypertension and metabolic syndrome among Asian Indians: the Indian Atherosclerosis Research Study.
Shanker J, Kanjilal S, Rao VS, Perumal G, Khadrinarasimhiah NB, Mukherjee M, Iyengar SS, Kakkar V

---

BMJ 2008 336(7636):123
A few lessons in screening for Gordon Brown.
Hart J

---

J Renin Angiotensin Aldosterone Syst 2007 8(4):190-8
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
Uresin Y, Taylor AA, Kilo C, Tschöpe D, Santonastaso M, Ibram G, Fang H, Satlin

---

Circulation 2008 117(3):440-9
New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications.
McGuire DK, Inzucchi S

---

Curr Diabetes Rev 2006 2(1):39-49
Hyperandrogenism, insulin resistance and hyperinsulinemia as cardiovascular risk factors in diabetes mellitus.
García-Romero G, Escobar-Morreale H

---

Curr Diabetes Rev 2006 2(1):51-61
Insulin and endothelial function: physiological environment defines effect on atherosclerotic risk.
Duncan E, Ezzat V, Kearney

---

Curr Diabetes Rev 2006 2(1):61-70
Factors influencing the hemodynamic and metabolic effects of insulin in muscle.
Rattigan S, Zhang L, Mahajan H, Kolka CM, Richards SM, Clark M

---

Curr Diabetes Rev 2006 2(1):71-98
Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
Simó R, Carrasco E, García-Ramírez M, Hernández

---

Curr Diabetes Rev 2006 2(1):99-112
Intravitreal triamcinolone for the treatment of diabetic macular edema.
Gómez-Ulla F, Marticorena J, Alfaro DV, Fernández M, Méndez ER, Rothen

---

Curr Diabetes Rev 2006 2(2):131-45
Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component.
Kles KA, Vinik A

---

Curr Diabetes Rev 2006 2(2):227-39
Clinical thiazolidinediones as PPARgamma ligands with the potential for the prevention of cardiovascular disease in diabetes.
de Dios ST, O'Brien RC, Little P

---

Curr Diabetes Rev 2006 2(3):295-305
The role played by serine proteases in the development and worsening of vascular complications in type 1 diabetes mellitus.
Finotti

---

Curr Diabetes Rev 2006 2(3):329-38
Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome.
Skrapari I, Tentolouris N, Katsilambros

---

Curr Diabetes Rev 2006 2(3):339-42
Therapeutic management strategies for type 2 diabetes.
Ramesh C, Gopal V, Sembulingam K, Nappinnai

---

Curr Diabetes Rev 2006 2(4):409-30
Platelet resistance to the anti-aggregating agents in the insulin resistant states.
Anfossi G, Russo I, Trovati

---

Curr Diabetes Rev 2006 2(4):431-47
Treatment of diabetic foot ulcer: an overview strategies for clinical approach.
Dalla Paola L, Faglia

---

Curr Diabetes Rev 2006 2(4):467-76
MTHFR gene polymorphism and diabetic retinopathy.
Maeda M, Fujio Y, Azuma

---

Recent Patents Cardiovasc Drug Discov 2007 2(3):162-80
Inhibitors of mammalian acetyl-CoA carboxylase.
Corbett JW, Harwood J

---

Chirurg 2007 Suppl():327-32
[Care of patients with chronic wounds in Germany]
Rüggeberg JA, Golbach

---

Adv Med Sci 2007 52 Suppl 1():126-30
The analysis of dehydroepiandrosterone sulphate concentration in elderly age women depending on coexisting disease states.
Kedziora-Kornatowska K, Beszczynska-Oles R, Kornatowski T, Szadujkis-Szadurski

---

PLoS Med 2008 5(1):e25
New insights into impaired muscle glycogen synthesis.
Groop L, Orho-Melander

---

Nature 2008 451(7178):509
Reviewer leaked Avandia study to drug firm.
Vastag

---

Med Arh 2006 60(6 Suppl 2):63-5
Stroke in patients with diabetes mellitus: a hospital based study.
Smajlovic D, Salihovic D, Ibrahimagic O, Sinanovic O, Burina

---

J Small Anim Pract 2008 49(1):17-25
Heart failure is common in diabetic cats: findings from a retrospective case-controlled study in first-opinion practice.
Little CJ, Gettinby

---

J Atheroscler Thromb 2007 14(6):303-9
Advanced endothelial dysfunction in diabetic patients with multiple risk factors; importance of insulin resistance.
Tsuchiya K, Nakayama C, Iwashima F, Sakai H, Izumiyama H, Doi M, Hirata

---

J Clin Hypertens (Greenwich) 2008 10(1 Suppl 1):40-8
Prompt, aggressive BP lowering in high-risk patients.
Jamerson KA, Basile

---

Metabolism 2008 57(2):274-9
Adiponectin gene polymorphism 45T>G is associated with carotid artery plaques in patients with type 2 diabetes mellitus.
Kim SH, Kang ES, Hur KY, Lee HJ, Han SJ, Kwak JY, Nam CM, Ahn CW, Cha BS, Lee H

---

Metabolism 2008 57(2):285-9
Association between serum estradiol concentrations and carotid atherosclerosis in men with type 2 diabetes mellitus.
Fukui M, Kitagawa Y, Kamiuchi K, Hasegawa G, Yoshikawa T, Nakamura

---

Compr Ophthalmol Update 8(5):245-56
Management of proliferative diabetic retinopathy.
Gündüz K, Bakri S

---

Compr Ophthalmol Update 8(5):257-8
Comments on: management of proliferative diabetic retinopathy.
Khorrami A

---

Eur J Ophthalmol 18(1):94-8
Urinary 8-hydroxydeoxyguanosine levels in diabetic retinopathy patients.
Dong QY, Cui Y, Chen L, Song J, Sun

---

J Wound Care 2008 17(1):12-6
Is chronic diabetic foot ulcer an indicator of cardiac disease?
Löndahl M, Katzman P, Fredholm O, Nilsson A, Apelqvist

---

Transplantation 2008 85(2):209-16
Risk factors for cardiovascular events after successful renal transplantation.
Vanrenterghem YF, Claes K, Montagnino G, Fieuws S, Maes B, Villa M, Ponticelli

---

J Cardiovasc Surg (Torino) 2008 49(1):103-11
Early mortality predictors in coronary artery bypass grafting patients required intra-aortic balloon pump in perioperative and postoperative periods.
Karimi A, Ahmadi H, Davoodi S, Marzban M, Movahedi N, Abbasi K, Salehiomran A, Sadeghian S, Hesameddin Abbasi S, Yazdanifard

---

Clin Nephrol 2008 69(1):63-4
Diagnostic markers for early detection of diabetic retinopathy and nephropathy.
Futrakul N, Futrakul

---

Klin Med (Mosk) 2007 85(11):50-4
[The evaluation of iron exchange parameters in patients with coronary atherosclerosis and type 2 diabetes mellitus]
Gorokhova SG, Atamanova MA, Muraseeva E

---

Curr Diabetes Rev 2007 3(1):25-31
Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes.
Fukui M, Kitagawa Y, Ose H, Hasegawa G, Yoshikawa T, Nakamura

---

Curr Diabetes Rev 2007 3(1):67-74
The anti-atherogenic effects of thiazolidinediones.
Stojanovska L, Honisett SY, Komesaroff P

---

Curr Diabetes Rev 2007 3(2):85-93
Progression of retinopathy in type 1 diabetic women during pregnancy.
Kaaja R, Loukovaara

---

Curr Diabetes Rev 2007 3(2):103-10
Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).
Renie G, Maingrette F, Li

---

Curr Diabetes Rev 2007 3(3):204-11
An overview of the effect of weight loss on cardiovascular autonomic function.
Maser RE, Lenhard M

---

Ann Thorac Surg 2008 85(2):681-9
Diabetic retinopathy and coronary artery disease from the cardiac surgeon's perspective.
Ohno T, Takamoto S, Motomura

---

Ann Thorac Surg 2008 85(2):690; author reply 690
Use of both internal thoracic arteries in diabetic patients.
Martínez-Sanz R, de la Llana R, Nassar I, Garrido

---

Clin Chem 2008 54(2):231-3
Uric acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis?
Koenig W, Meisinger

---

Pharmacotherapy 2008 28(2):170-92
Type 2 diabetes mellitus and heart failure.
Choy CK, Rodgers JE, Nappi JM, Haines S

---

Pharmacotherapy 2008 28(2):193-206
Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Malesker M

---

Diabetes Care 2008 31 Suppl 2():S111-2
The Controversies in Obesity, Diabetes and Hypertension (CODHy) meeting: what is it all about?
Raz I, Weiss

---

Diabetes Care 2008 31 Suppl 2():S155-60
Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld

---

Diabetes Care 2008 31 Suppl 2():S181-4
Possible role of oxidative stress in the pathogenesis of hypertension.
Ceriello

---

Diabetes Care 2008 31 Suppl 2():S190-3
Albuminuria: a great risk marker, but an underestimated target in diabetes.
de Zeeuw D, Raz

---

Diabetes Care 2008 31 Suppl 2():S194-201
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?
Basi S, Fesler P, Mimran A, Lewis J

---

Diabetes Care 2008 31 Suppl 2():S208-14
Primary prevention of cardiovascular disease in people with dysglycemia.
Bianchi C, Miccoli R, Penno G, Del Prato

---

Diabetes Care 2008 31 Suppl 2():S215-21
Cardiovascular complications in diabetes: targets and interventions.
Stirban AO, Tschoepe

---

Diabetes Care 2008 31 Suppl 2():S222-5
Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
Wienbergen H, Senges J, Gitt A

---

Diabetes Care 2008 31 Suppl 2():S226-8
Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?
Stirban AO, Tschoepe

---

Diabetes Care 2008 31 Suppl 2():S249-54
Diastolic pressure in type 2 diabetes: can target systolic pressure be reached without "diastolic hypotension"?
Osher E, Stern

---

Diabetes 2008 57(2):e4; author reply e5
Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial: Diabetes 56:1913-1921, 2007.
Chalew S, Hempe J, McCarter

---

J Periodontal Res 2008 43(1):103-10
Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects.
Colhoun HM, Slaney JM, Rubens MB, Fuller JH, Sheiham A, Curtis M

---

Invest Ophthalmol Vis Sci 2008 49(2):687-92
Impact of diabetic retinopathy on quantitative retinal nerve fiber layer measurement and glaucoma screening.
Takahashi H, Chihara

---

Invest Ophthalmol Vis Sci 2008 49(2):699-705
Retinal arteriolar hemodynamic response to a combined isocapnic hyperoxia and glucose provocation in early sight-threatening diabetic retinopathy.
Gilmore ED, Hudson C, Nrusimhadevara RK, Ridout R, Harvey PT, Mandelcorn M, Lam WC, Devenyi R

---

Invest Ophthalmol Vis Sci 2008 49(2):726-31
Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam

---

Invest Ophthalmol Vis Sci 2008 49(2):732-42
Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W, Xu G

---

Rev Esp Cardiol 2008 61(1):29-35
[Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population]
Ruiz Ortiz M, Romo E, Mesa D, Delgado M, Anguita M, López Granados A, Castillo JC, Arizón JM, Suárez de Lezo

---

Obesity (Silver Spring) 2008 16(1):125-9
Familial aggregation of metabolic syndrome and its components in a large Chinese population.
Feng Y, Zang T, Xu X, Xu

---

Clin Microbiol Infect 2008 14 Suppl 2():17-25
Treatment challenges in the management of complicated skin and soft-tissue infections.
Eisenstein B

---